Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line <em>Helicobacter pylori</em> Eradication: An Intervention Study in Southern Italy

The eradication of <i>Helicobacter pylori</i> (<i>H. pylori</i>) may be difficult due to antibiotic resistance. Indeed, after one failure, a second-line therapy is needed and a bismuth containing quadruple therapy (BQT) with a three-in-one capsule formulation is becoming very...

Descripció completa

Dades bibliogràfiques
Autors principals: Giuseppe Losurdo, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Vita Brescia, Maria Rendina, Enzo Ierardi, Alfredo Di Leo
Format: Article
Idioma:English
Publicat: MDPI AG 2022-01-01
Col·lecció:Antibiotics
Matèries:
Accés en línia:https://www.mdpi.com/2079-6382/11/1/78